...
首页> 外文期刊>Applied and Environmental Microbiology >Novel Microarray Design for Molecular Serotyping of Shiga Toxin-Producing Escherichia coli Strains Isolated from Fresh Produce
【24h】

Novel Microarray Design for Molecular Serotyping of Shiga Toxin-Producing Escherichia coli Strains Isolated from Fresh Produce

机译:从新鲜农产品中分离生产志贺毒素的大肠杆菌菌株的分子分型的新型芯片设计

获取原文

摘要

Serotyping Escherichia coli is a cumbersome and complex procedure due to the existence of large numbers of O- and H-antigen types. It can also be unreliable, as many Shiga toxin-producing E. coli (STEC) strains isolated from fresh produce cannot be typed by serology or have only partial serotypes. The FDA E. coli identification (FDA-ECID) microarray, designed for characterizing pathogenic E. coli, contains a molecular serotyping component, which was evaluated here for its efficacy. Analysis of a panel of 75 reference E. coli strains showed that the array correctly identified the O and H types in 97% and 98% of the strains, respectively. Comparative analysis of 73 produce STEC strains showed that serology and the array identified 37% and 50% of the O types, respectively, and that the array was able to identify 16 strains that could not be O serotyped. Furthermore, the array identified the H types of 97% of the produce STEC strains compared to 65% by serology, including six strains that were mistyped by serology. These results show that the array is an effective alternative to serology in serotyping environmental E. coli isolates.
机译:由于存在大量O型和H型抗原,对大肠杆菌进行血清分型是一个繁琐而复杂的过程。它也可能是不可靠的,因为从新鲜农产品中分离出的许多产志贺毒素的大肠杆菌(STEC)菌株无法通过血清学分型或仅具有部分血清型。设计用于表征致病性大肠杆菌的FDA大肠杆菌鉴定(FDA-ECID)微阵列包含分子血清分型成分,在此对其有效性进行了评估。对一组75个参考大肠杆菌菌株的分析表明,该阵列分别正确地鉴定了97%和98%菌株的O型和H型。对73种产STEC菌株的比较分析表明,血清学和阵列分别鉴定出37%和50%的O型,并且该阵列能够鉴定出16种不能进行O血清分型的菌株。此外,该阵列鉴定出97%的STEC产菌株中的H型,而血清学检测则为65%,其中包括六种因血清学错误分型的菌株。这些结果表明,该阵列是血清学环境大肠杆菌分离物中血清学检测的有效替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号